Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis

INTRODUCTION: To evaluate the efficacy and safety of dulaglutide 0.75 and 1.5 mg in patients with type 2 diabetes mellitus (T2DM) by baseline glycated hemoglobin (HbA1c) < 8.5% or ≥ 8.5% after 26 weeks of treatment. METHODS: Assessment of the Weekly AdministRation of dulaglutide in Diabetes (AWAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Miao, Yuan, Guo Yue, Zhang, Bin, Wu, Hai Ya, Lv, Xiao Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192976/
https://www.ncbi.nlm.nih.gov/pubmed/32277401
http://dx.doi.org/10.1007/s13300-020-00804-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192976/
https://www.ncbi.nlm.nih.gov/pubmed/32277401
http://dx.doi.org/10.1007/s13300-020-00804-2

Ejemplares similares